NCT00641186View on ClinicalTrials.gov

Trial of Xyrem for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson's Disease (PD)

PHASE2CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

July 31, 2008

Study Completion Date

November 30, 2008

Conditions

Parkinson Disease

Interventions

DRUG

sodium oxybate

4.5 to 9.0 grams per night

Sponsors

Collaborators (1)

Jazz Pharmaceuticals

All Listed Sponsors

collaborator

Jazz Pharmaceuticals

INDUSTRY

lead

Baylor College of Medicine

OTHER